The CWRU CFAR Clinical Research Core Facility will enhance AIDS Research Activities at CWRU by providing access to patients, clinical samples, the Special Immunology Unit Data Base and resources of the CWRU AIDS Clinical Trials Unit. The four main components of the Facility (Special Immunology Unit, Special Immunology Unit Data Base, AIDS Clinical Trials Unit and Outreach Educational Program) provide the means to optimize and promote collaboration between clinical and basic AIDS research at CWRU. University Hospitals Special Immunology Unit (SIU) is the largest HIV- care facility in Northeast Ohio and one of the largest in the Midwest. The SIU now provides high levels HIV-care to over 600 persons regardless of their financial resources. Moreover it is recognized in the community for outstanding service and therefore provides service to persons from all risk groups for HIV; its patients population is representative of the racial and ethnic diversity of our region. Through the novel 3- dimensional and interactive SIU Data Base, clinical and basic researchers can rapidly identify patients eligible for participation in clinical trials or clinical research projects. The data base (containing information on over 1,000 HIV+ patients having received care at CWRU) also provides an invaluable resource for descriptive or epidemiologic studies. Access to patients and patient specimens will be provided by the Clinical Core Study Coordinator who will identify eligible patients, explain the project, obtain informed consent, coordinate appointments among patients, staff and laboratory personnel, obtain and coordinate delivery of specimens to the appropriate laboratory. The CWRU AIDS Clinical Trials Unit is recognized within the ACTG for its outstanding performance in AIDS Clinical Trials. Access to resources of the ACTG- certified Virology and Immunology Laboratories, well-defined patient populations participating in clinical treatment trials, and the expertise of the ACTU investigators and staff in clinical trials design, implementation and data management-will facilitate coordination of basic and clinical AIDS research. In order to disseminate information about AIDS and AIDS research to the general public, community leaders and population with or at risk for HIV, a targeted Outreach Program has been developed. The details of each aspect of the Outreach Program will be tailored to each target population. The Program will be supervised by the Center staff who have developed credibility as recognized authorities and leaders in the community response to AIDS. The Outreach Program will develop a broader community understanding about HIV and AIDS research, fostering an atmosphere supportive of AIDS research and clinical trials in Northeast Ohio.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036219-02
Application #
3727724
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Silver, Nicholas; Paynter, Mary; McAllister, Georgina et al. (2018) Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay. AIDS Res Ther 15:18
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Martinez, Leonardo; Handel, Andreas; Shen, Ye et al. (2018) A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts. Am J Respir Crit Care Med 197:1214-1216
Fitzgerald, Wendy; Freeman, Michael L; Lederman, Michael M et al. (2018) A System of Cytokines Encapsulated in ExtraCellular Vesicles. Sci Rep 8:8973
Dazard, Jean-Eudes; Ishwaran, Hemant; Mehlotra, Rajeev et al. (2018) Ensemble survival tree models to reveal pairwise interactions of variables with time-to-events outcomes in low-dimensional setting. Stat Appl Genet Mol Biol 17:
Mukherjee, Pranab K; Chandra, Jyotsna; Retuerto, Mauricio et al. (2018) Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection. PLoS One 13:e0200285
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Tomalka, Amanda G; Resto-Garay, Ivelisse; Campbell, Kerry S et al. (2018) In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol 9:2552
Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge et al. (2018) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS 32:2517-2524
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786

Showing the most recent 10 out of 539 publications